Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration
The Lancet Microbe · 2026
DOI: 10.1016/j.lanmic.2025.101263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026. Verfasst von Abena S Amoah und 22 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Electronic address: a.s.amoah@lumc.nl. Hauptthemen laut MEDLINE: Vaccines, Immunogenicity, Vaccine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Lorentz Center, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Vaccines have improved global health substantially, preventing millions of deaths worldwide. However, striking variations in the immunogenicity and efficacy of some vaccines persist across populations. Notably, suboptimal responses to some vaccines, also known as vaccine hyporesponsiveness, have been observed in low-income and middle-income countries (LMICs) compared with high-income countries or in rural areas within LMICs compared with urban areas within LMICs. Environmental factors, host genetics, lifestyle, and nutrition contribute to immunological variations influencing vaccine responses, highlighting the need to identify key immune signatures that can be manipulated to overcome vaccine hyporesponsiveness. The integration of diverse datasets, accelerated by artificial intelligence, is essential to achieve this goal, which is currently hampered by the under-representation of data from LMICs. The HypoVax Global knowledge hub aims to address this gap by fostering international collaboration and compiling globally representative immunological data from population studies and vaccine trials. The hub offers a platform for high-dimensional data analyses, promotes equitable partnerships, and strives to ensure that all contributions lead to context-specific insights that can inform immunisation strategies to ultimately overcome vaccine hyporesponsiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Electronic address: a.s.amoah@lumc.nl.
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany; Institute of Medical Microbiology, University Hospital Münster, Münster, Ge…
- Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
- Center for Global Health, Weill Cornell Medicine, New York City, NY, USA; Department of Medicine, Weill Bugando School of Medicine, Mwanza, Tanzania.
- Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübinge…
- Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Förderung
- NIAID NIH HHS
- Lorentz Center
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Amoah, A. S., Agnandji, S. T., Bengtson, M., Downs, J. A., Esen, M., Giddaluru, J., Jochems, S. P., Kaisar, M. M. M., Makinde, J., Manurung, M. D., Mbow, M., Moncunill, G., Murugan, R., Mutai, J., Nakaya, H. I., Nkurunungi, G., Palmblad, M., Pyuza, J. J., Stam, K. A., …, & Participants of the Lorentz Center Workshop titled Connecting people to reverse vaccine hyporesponsiveness (2026). Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101263
Vancouver
Amoah AS, Agnandji ST, Bengtson M, Downs JA, Esen M, Giddaluru J, et al. Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration. The Lancet Microbe. 2026. doi:10.1016/j.lanmic.2025.101263
BibTeX
@article{Amoah2026,
author = {Amoah, Abena S and Agnandji, Selidji T and Bengtson, Michel and Downs, Jennifer A and Esen, Meral and Giddaluru, Jeevan and Jochems, Simon P and Kaisar, Maria M M and Makinde, Julia and Manurung, Mikhael D and Mbow, Moustapha and Moncunill, Gemma and Murugan, Rajagopal and Mutai, Jacqueline and Nakaya, Helder I and Nkurunungi, Gyaviira and Palmblad, Magnus and Pyuza, Jeremia J and Stam, Koen A and de Steenhuijsen Piters, Wouter A A and Walusimbi, Bridgious and Yazdanbakhsh, Maria and Participants of the Lorentz Center Workshop titled Connecting people to reverse vaccine hyporesponsiveness, Participants of the Lorentz Center Workshop titled Connecting people to reverse vaccine hyporesponsiveness},
title = {Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration},
journal = {The Lancet Microbe},
year = {2026},
doi = {10.1016/j.lanmic.2025.101263}
}
EUVIMED